Fulvestrant 50 mg/mL (Fulvestrant INJECTION) 50 mg/mL

Fulvestrant 50 mg/mL is an injectable medication used for hormone receptor-positive breast cancer treatment. This intramuscular injection is designed to help manage certain types of breast cancer in postmenopausal women. Learn more about Fulvestrant 50 mg/mL uses and effects.

Strength

50 mg/mL

Pack Size

2 SYRINGE, GLASS in 1 CARTON (0143-9022-02) / 5 mL in 1 SYRINGE, GLASS (0143-9022-01)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fulvestrant 50 mg/mL is primarily used in the treatment of hormone receptor-positive breast cancer. This medication is often prescribed for postmenopausal women with advanced breast cancer. Fulvestrant works by blocking the effects of estrogen, which can help slow the growth of cancer cells. It is typically used in cases where the cancer has spread to other parts of the body.

Side Effects

Common effects of Fulvestrant 50 mg/mL may include injection site reactions, such as pain, swelling, or redness. Some individuals may also experience fatigue, nausea, or headaches. These effects are generally mild and temporary, but it's important to discuss any persistent or severe symptoms with a healthcare provider.

Precautions & Warnings

Fulvestrant 50 mg/mL should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Proper storage and disposal of the medication are also crucial to ensure safety.

Avoid Interactions

Fulvestrant 50 mg/mL may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Fulvestrant, so it's best to consult with a healthcare professional before making any changes to your regimen.

References

Frequently Asked Questions

Fulvestrant 50 mg/mL is used for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Fulvestrant 50 mg/mL is administered as an intramuscular injection, typically by a healthcare professional.

Common side effects may include injection site reactions, fatigue, nausea, and headaches.

It is important to consult a healthcare provider before taking Fulvestrant 50 mg/mL with other medications to avoid potential interactions.

Fulvestrant 50 mg/mL should be stored as per the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.